NCT05627037

Brief Summary

The aim of this study will be to evaluate the non-inferiority of implants produced by additive manufacture loaded in 30 days when compared with those loaded in 90 days, in relation to marginal bone loss, after 01 (one) year of follow-up

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
75

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 31, 2022

Completed
2 days until next milestone

Study Start

First participant enrolled

November 2, 2022

Completed
23 days until next milestone

First Posted

Study publicly available on registry

November 25, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 2, 2023

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 2, 2025

Completed
Last Updated

June 19, 2025

Status Verified

June 1, 2025

Enrollment Period

1 year

First QC Date

October 31, 2022

Last Update Submit

June 16, 2025

Conditions

Keywords

implant, osseointegration

Outcome Measures

Primary Outcomes (1)

  • Marginal Bone Loss (MBL)

    Digital periapical radiographs will be taken at the implant installation (baseline) after 1 year. The radiographs will be taken using the parallelism technique with a positioner that supports the digital sensor in order to standardize the radiographs.

    1 year

Secondary Outcomes (5)

  • Implant success rate

    1 year

  • Modified Plaque Index (mPI)

    1 year

  • Modified Bleeding Index (mBI)

    1 year

  • Pocket probing depth (PPD)

    1 year

  • clinical attachment level (CAL)

    1 year

Study Arms (2)

Loading in 30 days

EXPERIMENTAL

Implant allocated to the study arm will be restored with a temporary restoration after 30 days of implant placement, that will be replaced with definitive restoration after 90 days of implant placement.

Device: Dental implant produced by additive manufacture

Loading in 90 days

ACTIVE COMPARATOR

Implant allocated to the study arm will be restored directly with the definitive restoration after 90 days of implant placement.

Device: Dental implant produced by additive manufacture

Interventions

In a split-mouth setup, each participant will receive two implants in the posterior region of the mandible or maxilla. After implant insertion, one implant will be randomly allocated to receive Temporary restoration after 30 days and definitive restoration after 90 days

Loading in 30 days

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients treated and referred by the Dental Clinic of the School of Dentistry of the University of São Paulo;
  • Individuals over 18 years and under 70 years of age;
  • Good general health;
  • signed Informed Consent Form;
  • Need for rehabilitation with dental implants in areas of mandible or posterior maxilla (premolars and/or molars);
  • bacterial plaque index ≤ 20% (Silness \& Loe, 1964);
  • bleeding rate of ≤ 20% (Loe \& Silness, 1963);
  • Sufficient alveolar bone volume for an implant of:
  • Length: 8 or 10mm
  • Diameter: 3.5mm, 4. 00mm or 4. 5mm
  • Bone quality type I-III;
  • No associated bone regeneration.

You may not qualify if:

  • Pregnant and lactating women;
  • Uncontrolled diabetes;
  • History of chemotherapy or radiotherapy in the last 5 years;
  • Radiotherapy in areas of the head and neck;
  • Use of immunosuppressants, bisphosphonate or prolonged use of corticosteroids;
  • Smokers;
  • Alcohol or drug abuse;
  • Untreated periodontitis;
  • History of previous bone increase in the implant installation region;
  • Presence of residual roots at the site receiving the implant;
  • Bone density type IV
  • Individuals with connective tissue disorders or metabolic diseases;
  • Postmenopausal osteoporosis or other systemic diseases that may affect bone metabolism;
  • Need for guided bone regeneration at the time of implant installation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

School of Dentistry - University of São Paulo

São Paulo, 05508-900, Brazil

Location

MeSH Terms

Interventions

Dental Implants

Intervention Hierarchy (Ancestors)

Dental MaterialsBiomedical and Dental MaterialsDental ProsthesisProsthodonticsDentistryProstheses and ImplantsEquipment and SuppliesManufactured MaterialsTechnology, Industry, and Agriculture

Study Officials

  • Giuseppe A Romito, PhD

    University of Sao Paulo

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
either the operator or the patient will be blinded for the primary outcome
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Split-Mouth Study Model
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

October 31, 2022

First Posted

November 25, 2022

Study Start

November 2, 2022

Primary Completion

November 2, 2023

Study Completion

November 2, 2025

Last Updated

June 19, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations